How Dr. Clay Siegall Is Saving Lives Through Antobody Based Therapies

Cancer Research is an ambitious project when being compared to other industries or sectors. This deadly disease has probably touched everyone’s lives in some form or another throughout the years. The good thing about living in this modern society is that we’re exposed to much more advancements in medicine than years of the past. Antibody Based Therapies are all the rage these days and it’s track record of success is a true testament of it’s progression. One of the top Biotechnology Companies in the world is Seattle Genetics of Bothell, Washington. Seattle Genetics has consistently produced many of the top cancer fighting medications in the world and the company has many more in the pipeline. This Biotech giant is run by leading doctor and scientist Clay Siegall. Seigall has been around for years in this industry and accumulated numerous awards for his great achievements. The brand’s flagship medicine (ADCETRIS) has one of the highest usage rates of any cancer fighting medication and as of 2016, it’s offered in over 60 countries worldwide.

Dr. Clay Siegall has a natural passion to help those in need and Seattle Genetics is no exception. The good doctor at present moment has the drug (ADCETRIS) in over 70 trials. This extensive testing is what he and the company is all about and it’s what set them apart from the competition. Much of the growth that’s been experienced by Seattle Genetics have come from the success of the drugs. The company has well over 700 employees to date and is one of Pugent Sound’s leading job producer. In the near future, this powerhouse is expected to release about 12 more drugs to the masses and employ up to an extra 100 people. For a more in-depth look at the growth of (SG) click http:www.bizjournals.com/seattle/blog/health-care-inc/2016/03/seattle-genetics-ambitious-plan-for-12-more-drugs.html

Dr. Siegall has helped the company with capital-raising activities (via) public and private financings since 2001. The good thing about it is that Seattle Genetics and Clay Siegall are on the same page, which means that that the fight against cancer will continue at full throttle.